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Abstract: We implement the cellular automata model proposed by Stauf-
fer and Weisbuch in 1992 to describe the response of the immune system to
antigens in the presence of medications. The model contains two thresholds,
θ1 and θ2, suggested by de Boer, Segel, and Perelson to present the minimum
field needed to stimulate the proliferation of the receptors and to suppress it,
respectively. The influence of the drug is mimicked by increasing the second
threshold, thus enhancing the immune response. If this increase is too strong,
the immune response is triggered in the whole immune repertoire, causing
it to attack the own body. This effect is seen in our simulations to depend
both on the ratio of the thresholds and on their absolute values.
Keywords: cellular automata, phase transitions, thresholds, medical treat-
ment, BSP model
1 Introduction
Too much of a good think may be bad. We know this from alcoholic drinks;
few readers have lost as much money as Bill Gates did in 2000; and antibiotics
not only saved many human lives but also created resistant strains of bacteria.
Our immune system protects us against many diseases but may also go wrong
and attack the own body, leading e.g. to many allergic reactions. Allergic
reactions are unexpected reactions that are not caused by the normal action
of the medicine and are due to stimulation of the immune system by the
drug. The immune system may react in a variety of ways, most commonly
by causing proliferation of lymphocytes which form antibodies. Antibodies
may cause reactions when they combine with the drug.
The present note tries to model something similar: If we apply too much
of a medicine strengthening our immune system, can it cause the immune
cells to attack “everything” including healthy tissue, besides attacking the
foreign antigen (infectious disease)? The antigen-specific immunoglobulin
1
interacts with mast cells to protect the host against the invading parasite.
However, the same antibody-cell combination is also responsible for typical
allergy or immediate hyper-sensitivity reactions such as hay fever, asthma,
hives and anaphylaxis.
Presumably many immunological models [1, 2, 3] would give such an
effect. To avoid adding another example to the already large number of
immunology models of the last decades, we selected a variant of the de Boer-
Segel-Perelson model [4], which has been cited well in the last decade. We use
one of the simplifications of [5] called BSP II there; since an even simpler ver-
sion, BSP III, has been criticised [6], we take a somewhat more complicated
and realistic version BSP II and explain it in the next section. Thereafter
we bring our results and summarise our findings.
2 Model
The immune repertoire is represented by a five-dimensional shape space of lin-
ear dimension L containing L5 possible types of antibodies, which the immune
cells may produce to fight against as many possible types of antigens. Each
of the five dimensions corresponds to give different criteria (length, electric
charge, curvature, ...) by which our immune system characterises the anti-
gen; for L = 7 this parameter may take the values x = −3,−2,−1, 0, 1, 2, 3.
The five components x then give a five-dimenensional vector r such that the
null vector is the lattice centre. Just as a key has to fit a lock, apart from
minor scratches, the antibody has to be complementary to the antigen in or-
der to detect and neutralise it. Thus an antigen with x = −2 may be killed
by an antibody with x = +2; more generally an antigen at a position –r in
the shape space is neutralised by its complementary antibody at a position
r, or by very similar antibodies. We define as very similar the ten nearest
neighbours of r, which differ from the fully complementary site r only by a
Hamming distance of one; but each of these ten neighbours contributes only
one tenth as much to the immune response as the fully complementary r.
Thus if b(r) is the concentration of B cells (producing antibodies) at a site r
of the shape space, then
h(−r) = b(r) + 0.1
∑
n
b(r
n
) (1)
is the influence of the immune system on the site –r; the sum runs over the
2
ten neighbours r
n
of r.
Following the Weber-Fechner law of physiology, that effects increase often
only logarithmic with concentration or physical amplitude, we assume the
concentrations b to vary exponentially:
b = eB (2)
where the B’s are integers varying between 0 and 20. The rule for our si-
multaneous updating is: B increases by one if and only if the influence h at
that site in the shape space lies between two thresholds θ1 and θ2; otherwise
it decreases by one. (If B is zero it stays at zero; parameters were chosen
such that B does not surpass 20). The “naive” immune system thus has
B = 0 everywhere, i.e. only one B cell per a possible shape. This threshold
automata rule mimics the bell-shaped natural immune response. Now we
completed the definition of model BSP II.
(Actually the BSP model does not deal with antigen-antibody reactions
but with the underlying idiotypic-antiidiotypic reactions within the immune
network; therefore a field h of the proper value θ1 < h < θ2 increases and not
decreases the corresponding b and B.)
Initially we put the whole lattice to B = 0 except at one line of length L
or one hyper-plane of L4 sites; this initialisation models the initial response
to a specific antigen. We then ask whether this initial response remains small
and localised around the initial region, or becomes large by spreading over
the whole lattice. We thus monitor the sum
S =
∑
r
b(r) (3)
over the whole lattice; since our initially excited region is relatively small,
it does not matter whether or not we subtract from this overall sum the
sum over only the initially excited region. Thus a healthy localised im-
mune response means S/L5 ≃ 1 while a dangerous over-reaction means
S/L5 ≫ 1. Our simulations below show a clear separation between these
two behaviours. Fortran programs are available from anap@phys.uni-sofia.bg
and stauffer@thp.uni-koeln.de.
To simulate the dangers of excessive medication we assume that the
medicine helps the immune system by increasing the window between θ1
and θ2 within which the immune response is positive. We made a test where
the medication takes effect only after a few interactions (much shorter delays
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Figure 1: Double-logarithmic plot of normalised response B/L5 versus scaled
time t/L where t is the number of sweeps through the lattice. Different
symbols correspond to different lattice sizes L = 31, 37, 47, and 53; θ1 =
10 throughout. The upper curves have θ2 = 200, the intermediate curves
θ2 = 100, and the flat line near unity mostly θ2 = 50. However, one of the
θ2 = 100 curves stays flat, and one of the θ2 = 50 simulations rises and is the
lowest curve in this figure.
than in the aging studies of [7]) and then found the results to be the same
as if the medication effects start with the beginning of the simulation. Thus
all simulations reported below use one time-independent pair of thresholds,
with smaller θ2/θ1 corresponding to no medication, and larger θ2/θ1 to the
effect of medicine. At what threshold θ2, for fixed θ1, does the system switch
from healthy localised to dangerous, huge, spreading immune response?
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Figure 2: Semilogarithmic plot of the number S/L5 of B cells per site as a
function of θ2 for fixed θ1 = 10 and L = 31. We see first a jump (first-order
phase transition) from unity to about 100, and then a further jump to about
300. Only in the small left region the immune system works properly, with
the first jump it deteriorates, and with the second jump it becomes really
bad.
3 Results
Figure 1 shows how the number of B cells per site varies as a function of
the second threshold θ2 for a θ1 equal to 10. The antigen presentation was
simulated by randomizing one line of length L, while all other sites were set to
B = 0. The results usually indicate that for θ2 = 5θ1 the B cell concentration
stays small while for θ2 = 10θ1 it spreads. This general trend can be violated
in some cases, see the caption to Fig.1. The constant value (the plateau) is
higher for an overdosed drug, meaning that the system memorises the amount
of medicine absorbed. Figure 2 shows two phase transitions a a function of
θ2.
The initial configuration with randomly flipped sites in one hyper-plane
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Figure 3: Double-logarithmic plot of non-normalised response B versus time
t for a high value of the first threshold, θ1 = 50. A healthy response of the
system is observed for R = 5, i.e. θ1 = 250 (+). The R = 10 ( θ1 = 500)
case is shown with (x), and R = 20 with (*).
models a higher response than previously. We observe different time be-
haviours of the system depending on both the ratio R = θ1/θ2 and the
θ1-value.
If the first threshold θ1 is 50, then the number of B-cells remains basically
unchanged for R less or equal to 5, increases smoothly for R about 10, or
has a prominent peak for R about 20. The time at which the number of B
cells reaches its maximum value increases with the θ2-value, Fig.3.
A similar study with small θ1-values (5,10) shows an opposite time de-
pendence: the peak appears at shorter times with the R-increase, Fig.4.
However, the shapes change similarly, i.e. a smooth increase to the maxi-
mum B-value for R = 5, 10. Note that a healthy response (one B cell per
a site) is observed for much smaller R-values, about 2, e.g. for a narrower
window. This is a general trend, the smaller θ1-value, the narrower window
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Figure 4: Double-logarithmic plot of non-normalised response B versus time
t for a low value of the first threshold, θ1 = 5. A healthy response of the
system is observed for R = 2, denoted with (+), while R = 5 (x) gives a
smoothly increasing curve, similar to the curve for R = 10 in Fig.3. The
R=20 case is shown with (*).
for a healthy response.
A different time-dependence of the immune response is sometimes ob-
served: for example, if θ1 = 30 and R = 20, the number of the B cells
increases again after some time being almost constant (at a plateau), Fig.5.
Thus it seems that the model is able to describe the ’unhealthy’ response of
the immune system to drugs if a specific time of treatment is surpassed.
4 Summary
Using a variant of the well-established BSP model we show that a properly
working immune system may go wrong completely and attack “everything”
if the second threshold is increased too much. This phase transition may
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Figure 5: Double-logarithmic plot of non-normalised response B versus time
t for one ’special’ case, θ1 = 30. The system responses normally upto R = 10
(+,x); for R = 20 (*) the plateau is observed for some time, after then the
B-cells increase again.
explain some autoimmune diseases arising from medication.
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